MSB 3.21% $1.13 mesoblast limited

Ann: COVID ARDS Trial Topline 60-Day Results, page-1568

  1. 7,655 Posts.
    lightbulb Created with Sketch. 6934
    What Apology@Cato I offered some useful data to MSB investors from a cited huge national trial in the UK. You presumed to cast doubt on a well reported and transparent study with reference to some headlines that you didn't even bother checking their validity. I will keep posting information, data and insight. You keep up with your opinions Cato. I know which is more helpful to MSB investors.

    Apologies to others for this handbagging. I try to post usueful stuff on here because I am grateful for a dozen or so really insightful posters. And then there are the other posters who just make noise....

    @eyeswideopen I've already begun peppering NSW health and officials with details of MSB's C-19 ARDS results.
    Last edited by bedger: 09/07/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.